J&J tests direct CAR-T marketing with first Carvykti ad

J&J tests direct CAR-T marketing with first Carvykti ad

The new direct-to-consumer ad signals J&J’s confidence in its capacity to meet demand for the cell therapy after earlier manufacturing struggles.

J&J Ventures into Direct CAR-T Marketing with Carvykti Ad Campaign

Johnson & Johnson has taken a bold step in the realm of cancer treatment marketing by launching a direct-to-consumer ad for Carvykti, its CAR-T cell therapy for multiple myeloma. The ad is set to air on streaming platforms like YouTube, Paramount, and Roku, marking a rare move in the promotion of cell therapies, which are typically complex and personalized treatments. The campaign aims to reach patients who may not be treated at specialized acad…